Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VNN1 | O95497 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 10/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 8/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.37 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL30838028 | 1.00 | VNN1 (0.42) | VNN1HCRTR1HCRTR2CYP11B1CYP11B2 | |
| SCHEMBL27095229 | 0.93 | VNN1 (0.42) | VNN1HCRTR1HCRTR2CYP11B1CYP11B2 | |
| Fumaric Acid SCHEMBL30838106 | 0.88 | CHRM3 (0.42) | VNN1CYP11B1CYP11B2 | |
| Formic Acid SCHEMBL30838050 | 0.82 | VNN1 (0.55) | VNN1HCRTR1HCRTR2CYP11B1CYP11B2 | |
| Formic Acid SCHEMBL30838102 | 0.82 | VNN1 (0.55) | VNN1HCRTR1HCRTR2CYP11B1CYP11B2 | |
| Formic Acid SCHEMBL30838081 | 0.80 | CHRM3 (0.41) | CYP11B1CYP11B2 | |
| Fumaric Acid SCHEMBL30838053 | 0.79 | IRAK4 (0.38) | CYP11B1CYP11B2CRHR1 | |
| Fumaric Acid SCHEMBL30838000 | 0.79 | IRAK4 (0.38) | CYP11B1CYP11B2CRHR1 | |
| SCHEMBL30837966 | 0.78 | TRPV1 (0.48) | VNN1HCRTR1HCRTR2CYP11B1CYP11B2 | |
| Formic Acid SCHEMBL30838073 | 0.78 | PRKCQ (0.41) | VNN1CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240059677-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | CEREVANCE LTD (GB) | 2024-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240059677-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | CHRNA6, CHRM2, CHRNA1 | VNN1 1828/4885HCRTR1 390/4885HCRTR2 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.